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Abstract. Indonesia is one of the few countries in the world with very high burden of 
tuberculosis (TB). Tubercular pleural effusion (Pleural TB) is the most common form of 
extra-pulmonary TB, however the remains a common clinical challenge. This research from 
May 2017 through September 2017 a total of 42 patients with exudative lymphocytic pleural 
effusions suspected to pleural tuberculosis were enrolled in this study. Adenosine deaminase 
(ADA) and Gene X-pert were examined from pleural fluid. Diagnosis was made clinically or 
based from sputum/pleural fluid culture. The result of this research showed out of all 
participants, 64,3% (27/42) had ADA in positive level (>40 IU/L) and 31% (13/24) had Gene 
X-pert positive Mycobacterium Tb. The Gene X-pert sensitivity was 40.7% with specificity 
86.6%, PPV and NPV were 44.8% and 57.1% respectively. Kappa Compatibility study show 
that Gene X-pert point was 0.227 (p 0.066). The usefulness of Gene X-pert to diagnose 
pleural TB is limited by its poor sensitivity.  Gene X-pert cannot be used as single diagnostic 
tool for tuberculous pleural effusion. 
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Abstrak. Indonesia adalah salah satu dari sedikit negara di dunia dengan beban tuberkulosis 
(TB) yang sangat tinggi. Efusi pleura tuberkular (TB pleura) adalah bentuk TB 
ekstrapulmoner yang paling umum, namun tetap merupakan tantangan klinis yang umum. 
Penelitian ini dari Mei 2017 hingga September 2017 total 42 pasien dengan efusi pleura 
limfositik eksudatif yang diduga menderita tuberculosis pleura yang terdaftar dalam 
penelitian ini. Adenosine deaminase (ADA) dan Gene Xpert diperiksa dari cairan pleura. 
Diagnosis dibuat secara klinis atau berdasarkan dari kultur cairan sputum / pleura. Hasil 
penelitian menunjukkan dari semua peserta, 64,3% (27/42) memiliki ADA pada tingkat 
positif (> 40 IU / L) dan 31% (13/24) memiliki Gene Xpert positif Mycobacterium Tb. 
Sensitivitas Gene Xpert adalah 40,7% dengan spesifisitas 86,6%, PPV dan NPV masing-
masing 44,8% dan 57,1%. Studi Kappa Compatibility menunjukkan bahwa Gene Xpert point 
adalah 0,227 (p 0,066). Kegunaan Gene Xpert untuk mendiagnosis TB pleura dibatasi oleh 
sensitivitasnya yang buruk. Gene Xpert tidak dapat digunakan sebagai alat diagnostik 
tunggal untuk efusi pleura TB. 
Kata Kunci: Gene Xpert MTB / RIF, Efusi pleura Tuberkulosis, Adenosin Deaminase 
Received [25 May 2019] | Revised [30 May 2019] | Accepted [31 May 2019] 
Sumatera Medical Journal (SUMEJ) Vol. 02, No. 02, 2019                                                            
 
80 
1. Introduction 
Tuberculosis is still an infection problem worldwide. This disease can infect most of the body 
organs, especially lungs [1]. Pleural tuberculous is the most common form of extra-pulmonary 
TB and presented as pleural effusion. This medical condition remains a common medical 
challenge because the diagnose was difficult to enforced [2][3]. In Indonesia, most physicians had 
made the diagnosis based on clinical complaints, thoracic radiological examination, acid fast 
bacilli staining or microbiologic culture which supported to tuberculosis infection [4]. 
Recognizing the difficulty of establishing a diagnosis of tuberculous pleural effusion, many 
studies have been done to find a more optimal method of assisting the diagnosis of the disease 
such as pleural fluid ADA level, and Gene X-pert [5]. The aims of this study are to evaluate the 
accuracy of Gene X-pert and compatibility as diagnostic tools. 
2. Methodology 
A diagnostic test was done at the department of pulmonology and respiratory medicine, Haji 
Adam Malik General Hospital Medan, from 1st May to 30th September 2017. 45 patients with 
suspected tuberculous pleural effusion were enrolled. After obtaining an informed consent all 
patients with inclusion criteria such as; > 18 years old, thoracix Xray with pleural effusion with 
or without tubercular lesions and agree to performed thoracocentesis were performed detailed 
physical examination, routine TB examination and thoracocentensis. Pleural fluid samples were 
collected and performed chemical examination, cytology, microbiology culture, ADA and Gene 
X-pert. All subjects also given oral antituberculosis drugs as diagnostic therapy. Four patients 
with abnormal coagulation status, transudative pleural effusion, non-tuberculous pleural effusion 
that has been diagnosed before and patients without improvement in clinical symptom or thoracic 
Xray after intensive phase of oral anti-tuberculosis drug were excluded.  
In the descriptive analysis, quantitative variables were expressed as mean+standard deviation. 
Discrete variables are presented as number of cases and percentages. Sensitivity and specificity 
were calculated using standard procedures. All data were analysed using the SPSS statistical 
package. 
3. Results 
A total of 45 patients were evaluated, three samples were excluded because there is no 
improvement in the physical examination evaluation and thoracic Xray after intensive phase oral 
anti-tuberculosis drugs. Most of the patients were man (69%) with a mean age 45.17+14.69 years. 
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Table 1 Baseline Characteristic of samples 
 
 
Only 31 % samples have a normal body mass index and nutritional status with mean 18.30+2.61 
kg/m2. 52.4% subjects with indoor work places and only 16.7% with bachelor educational level. 
81% samples did not have infiltrative TB lesion in their thoracic Xray. 
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Table 2 Rifampicine resistant from gene Xpert examination 
 
Table 3 Result of Diagnostic Test 
 
All samples were diagnosed as tuberculous pleural effusion, which 33.3% cases diagnosed based 
of sputum/pleural fluid culture with positive Mycobacterium Tb and 66.7% diagnoses based of 
clinical physical examination. 64.3% samples had ADA level > 40 IU/L and only 31% had a 
positive Mycobacterium Tb in Gene Xpert (Table 1). 
Pleural fluid Gene Xpert obtained from real-time polymerase chain reaction system. This system 
also detected the Mycobacterium Tb deoxyribonucleic acid (DNA) which had mutation and 
resistant to rifampicin showed on Table 2. 
Table 3 showed 2x2 table for calculation of sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) of Gene Xpert which were found to be 40.7%, 86.6%, 
84.6% and 44.8% respectively. Accuration was found to be 57.1% for Gene Xpert to diagnosed 
tuberculous pleural effusion. Kappa compatibility study was performed and true compatibility 
value was 0.227 (p 0.066) for Gene Xpert compared to ADA examination. 
4. Discussion 
Tuberculosis is an endemic disease in Indonesia, which ranked third place worldwide, after China 
and India [2], [5]. World Health Organization (WHO) data confirmed that mostly patients had a 
poor economic status and at young age [2]. In our study, mostly tuberculous pleural effusion 
patients had income below the minimum regional salary and also at < 50 years old. In our study 
66.7% patients with malnutrition status. In line with study which performed by Gupta et all, that 
malnutrition will convenient to tuberculosis infection [6]. 
Indoor workplace, especially with poor ventilation will incrases the germ in the air and facilitate 
the tuberculosis infection [5], [7]. Our study also proved it, which 52.4% patients in our study had 
indoor workplace.  
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Pleural fluid ADA levels can be an easy, fast, relatively affordable and applicable diagnostic tool 
in diagnose pleural effusion due to tuberculosis because it has good sensitivity (95.8%) and 
specificity (90.9%) [8] [9]. In line with Kumari et all that said ADA level had high sensitivity to 
diagnose tuberculous pleural effusion [10], [11]. In our study, there was found 64.3% samples 
with ADA level positive (>40 IU/L). 
The Gene Xpert MTB / RIF examination is an automatic quantitative polymerase chain reaction 
(PCR) technique, that able to detect Mycobacterium Tb in 2 hours and able to provide information 
on the successful of rifampicin therapy [12]. This examination has been validated using sputum 
samples and finally approved by WHO as a rapid check for positive and negative smear acid fast 
bacilli staining bacteria from an airway sample [2]. Similar results are also expected in diagnosing 
tuberculous pleural effusion with a sample of pleural fluid [13]. 
Although Gene Xpert can be used to enforce tuberculosis diagnose from a various fluid 
specimens, most studies are obtained in diagnosing tuberculous meningitis with cerebrospinal 
fluid samples and few studies use this examination technique to diagnose tuberculous pleural 
effusion [13], [14]. One study conducted by Meldau et al in 2014 of 93 subjects who were 
suspected of having tuberculous pleural effusion gave results that Gene Xpert had a sensitivity of 
22.5% and a specificity of 98%. This proves that this examination is not sensitive but specific in 
diagnosing tuberculous pleural effusion [13]. Equivalent results were also obtained in our study, 
where the sensitivity of Gene Xpert was only 40.7% but the specificity was 86.6% in diagnosing 
tuberculous pleural effusion. This may be happen, considering that the pleural fluid is basically 
asepsis and new bacteria are found in the pleural fluid after > 28 days of infection, which in one 
study said after 28 days only a few germs are exposed in the pleural fluid compared to the pleural 
tissue [13], [15], [16]. Gene Xpert examination, which basically uses PCR technique can only 
detect germs based on bacterial DNA, in other words there should be germs in the sample fluids 
even if only slightly [2]. Its explains that there is a difference in the results on samples that are 
centrifuged and not centrifuged. Generally, a single examination using Gene Xpert only is not 
appropriate in diagnosing tuberculous pleural effusion. From this study, we know that establishing 
the diagnosis of tuberculous pleural effusion is not a simple matter, where confirmation is required 
from other diagnostic tools, regardless of clinical outcomes and diagnostic therapy. 
5. Conclusion 
The usefulness of Gene Xpert to diagnose pleural TB is limited by its poor sensitivity.  Gene 
Xpert cannot be used as sigle diagnostic tool for tuberculous pleural effusion. 
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